CA-CTC-GLOBAL
16.3.2020 11:02:09 CET | Business Wire | Press release
In another major advancement of conductor technology, CTC Global has launched the ACCC InfoCore™ System. This system provides fast, accurate assurance that the ACCC® Conductor has been installed properly.
The ACCC InfoCore™ System reduces real-world conductor installation risk experienced by utilities, contractors and lineman across the globe. These dedicated professionals know that even with the best tools, equipment and field conditions, accidents can happen. By using a proprietary infrared light system, special fibers in the core, and a robust data-capture methodology, the InfoCore System can confirm the post-stringing integrity of the conductor in minutes. This capability is uniquely valuable to utilities and contractors because of the added confidence it provides.
“CTC Global and its manufacturing partners have supported the installation of roughly 100,000 kilometers of ACCC Conductor at over 750 projects, for more than 250 utilities in over 50 countries and in virtually every type of terrain and ecosystem imaginable. This massive body of experience has taught us two things – First, ACCC Conductors are easy to install with proper tools and use of simple handling guidelines. And second, the real world is an unforgiving place for every engineered product and project,” said J.D. Sitton, CTC Global’s CEO. He continued: “CTC Global’s utility customers asked for a fast, accurate and simple-to-use method for confirming post-installation integrity of their ACCC Conductor installations. The InfoCore System does this very effectively.”
Anne McDowell, VP, Commercial Operations for CTC added: “Our team worked closely with CTC’s manufacturing partners and key utilities to develop, test and optimize the InfoCore System.” She continued: “I am pleased to announce the first full-scale commercial deployment of ACCC InfoCore Conductor for Elia, on the upgrade of a 66 kV line near Mons, Belgium. The upgraded line serves an important new data center in the region. The InfoCore System has exceeded all expectations.”
About CTC Global:
CTC Global is the privately held developer, marketer and manufacturer of the patented carbon fiber composite core used in ACCC® Conductor the high performance, high voltage power line solution. CTC Global serves utility and industrial companies around the world and has provided ACCC Core used in over 750 ACCC conductor projects representing nearly 100,000 kilometers of high-performance, energy-efficient overhead conductor in service today. CTC Global is headquartered in Irvine, California. For more information please visit www.ctcglobal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200316005155/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom